Bayer considers expanding use of Nubeqa on new data from prostate cancer trial
Bayer said its drug Nubeqa was shown to slow the progression of a certain type of prostate cancer in a late-stage trial, bolstering growth prospects for one of the German drugmaker’s key pharmaceuticals. The drug is already approved in other prostate cancer treatments.
BELIEBTE BEITRÄGE
Bluetongue outbreak in a Portuguese sheep farm has broken out
September 19, 2024
Austria says disaster fund to rise to 1 billion euros
September 19, 2024
Portugal gets help from Spain and Morocco in response to fires
September 19, 2024
Drought reduces Amazon rivers to historic lows
September 19, 2024
LIVEÜBERTRAGUNG